UAE
Bahrain
Jordan
Kuwait
Oman
Qatar
Saudi ArabiaHealth News
Non-Amputees Experience Phantom Limb Sensation
Date: Apr-11-2013Non-amputated individuals can actually experience the illusion of having a phantom hand, according to a new study in the Journal of Cognitive Neuroscience. The research was conducted by neuroscientists at the Karolinska Institutet in Sweden who explained that the sensation of having a physical body is not as obvious as some people may assume. Nearly all patients who have had an arm or leg amputated feel a phantom limb - a realistic sensation that the missing limb is still attached to the body...
"Death With Dignity" Program Is Rarely Used
Date: Apr-11-2013Doctors, patients, and their families have been okay with a "death with dignity" physician-assisted suicide program that is available to patients with fatal cancer at a Seattle clinic, a study suggests. In the final months of 2011, the majority of 255 Washington residents who had a prescription for lethal medication to terminate their lives under the state's Death with Dignity Act had been diagnosed with terminal cancer...
CPAP Improves Work Productivity For Sleep Apnoea Patients
Date: Apr-11-2013Continuous positive airway pressure (CPAP) is effective at increasing work productivity, according to a new study. The study will be presented today at the Sleep and Breathing Conference in Berlin, organised by the European Respiratory Society and the European Sleep Research Society. Previous research has demonstrated that people with sleep apnoea are less productive at work, usually due to excessive daytime sleepiness. This study aimed to assess whether continuous positive airway pressure (CPAP) improved productivity at work...
Melanoma Succumbs To Natural Plant Substance Gossypin In Lab Tests
Date: Apr-11-2013For the first time, using lab tests on cell cultures and mice, researchers in the US have shown that gossypin, a naturally-occurring substance found in plants, may be an effective treatment against melanoma, the deadliest form of skin cancer. Hareesh Nair of the Texas Biomedical Research Institute, and colleagues, write about their findings in the April issue of Molecular Cancer Therapeutics. In their background information they explain that previous studies have shown gossypin, a flavone originally isolated from the hibiscus plant (H...
Shire Launches Report That Quantifies The Health, Psycho-Social And Economic Impact Of Rare Diseases
Date: Apr-11-2013New findings reveal the substantial burden of rare diseases due to lack of resources, financial challenges and emotional unrest Shire plc (LSE: SHP, NASDAQ: SHPG) have launched a Rare Disease Impact Report, which uncovers the health, psycho-social, and economic impact of rare diseases on patient and medical communities in the United States (US) and United Kingdom (UK)...
'Mobility Shoes' Take A Load Off For Knee Osteoarthritis Suffers
Date: Apr-11-2013New research suggests that patients with knee osteoarthritis (OA) who wear flat, flexible footwear (mobility shoes) had significant reduction in knee loading - the force placed upon the joint during daily activities. Results published in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), show that long term use of the mobility shoes helped OA patients adapt their gait, or how they walk, which improved knee loading, even when the mobility shoes were no longer worn...
Inostics DNA Blood Test Provides A More Precise Picture Of Resistance Mutations Than Traditional Biopsies
Date: Apr-11-2013A study presented at the AACR Annual Meeting 2013 indicates that a DNA blood test using Inostics' BEAMing Digital PCR can detect more mutations associated with secondary drug resistance in GIST patients than testing conventional biopsies. Therapies targeted to specific cancer-causing mutations may be the most promising strategy in cancer treatment. However, inter- and intra-tumor heterogeneity pose a significant challenge to maximizing therapeutic efficacy...
New Protocol Design Approaches Will Improve Clinical Trial Performance And Efficiency, According To Tufts Center For The Study Of Drug Development
Date: Apr-11-2013Growing protocol complexity-responsible for longer clinical study times, greater difficulty in recruiting volunteers, and rising drug development costs-is spurring new approaches to optimizing protocol design, according to leaders from the research-based drug industry recently convened by the Tufts Center for the Study of Drug Development. A key challenge for drug developers is to design protocols-plans detailing the methodology of a clinical study-that address increasing scientific, regulatory, and operating demands while maintaining patient safety and study feasibility, the panel agreed...
Dementia Care Study Confirms Dramatic Reduction In Use Of Antipsychotics And A Range Of Drugs With Corresponding Improvement In Wellbeing
Date: Apr-11-2013A new study of residents in specialised dementia care homes has confirmed a reduction, averaging 48 per cent, in the requirement for antipsychotic medication, together with dramatic reductions in usage of a range of other medications and a corresponding improvement in the wellbeing of participants. Analysis of data from 16 homes in the PEARL specialised dementia care programme developed by Four Seasons Health Care found that on average across all participants, in addition to the reduction in antipsychotics use: Medication to alleviate anxiety reduced by 40 per cent...
Atox Bio Publishes Data Demonstrating The Broad Therapeutic Effect Of Its Flagship Product In Treating "Flesh Eating Bacteria"
Date: Apr-11-2013Atox Bio announced new data in an animal model of necrotizing soft tissue infection (NSTI), commonly known as "flesh eating bacteria" demonstrating that administration of a single dose of AB103, given several hours after infection even without any antibiotics, increased survival in animals, and reduced tissue necrosis, inflammation and bacterial burden at the site of infection without compromising the immune response. NSTI or flesh eating bacteria is a life-threatening bacterial infection with significant morbidity and no currently approved therapies...
Stay Connected
